Dermatocorticosteroïden bij constitutioneel eczeem

Atopic dermatitis (constitutional eczema) is a chronic, relapsing, and common skin disorder that is a public health problem because of its prevalence, cost, and influence on the quality of life. Topical corticosteroids are the main treatment. These drugs are divided into four potency classes, with recommendations regarding the maximal amount (expressed in finger-tip units) to be applied per class. During exacerbations, topical corticosteroids should be applied twice daily, to bring the dermatitis under control as quickly as possible. If the response to treatment is good, then a maintenance dose can be used, with intermittent application of the topical corticosteroid. During remission, preventive use of topical corticosteroids can lead to a longer dermatitis-free interval. Unfortunately, patients, carers, and health professionals are reluctant to use topical corticosteroids, and the provision of inconsistent information by health professionals can further increase patients' and carers' concerns about using these agents. The main concern is thinning of the skin, but irreversible atrophy is rare if topical corticosteroids are used correctly. Suppression of the hypothalamus-pituitary-adrenal axis can occur with highly potent topical corticosteroids. Research has shown that the risk of systemic side effects is low with fluticasone proprionate and mometasone furoate.